C051 | PRELIMINARY EFFICACY AND SAFETY OF LUSPATERCEPT (LUSPA) INITIATED AT THE MAXIMUM APPROVED DOSE IN TRANSFUSION-DEPENDENT LOWER-RISK MYELODYSPLASTIC SYNDROMES IN THE MAXILUS STUDY

BACKGROUND: LUSPA improved red blood cell transfusion independence (RBC-TI) in patients (pts) with TD LR-MDS in the COMMANDS and MEDALIST studies, with most pts titrating to the maximum dose. We report preliminary efficacy and safety from the phase 3b MAXILUS study (NCT06045689) where pts with TD L...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	M.G. Della Porta, M.D. Campelo, V. Santini, R. Buckstein, L. Adès, L. Sahagun, G. Das, T. Bryant, T. Zelinsky, Y. Lai, D. Miteva, A. Mcbride, K. Madry, D. Valcarcel, J.M. Torregrosa-Diaz, D. Deeren, S. Grosicki, S. Venugopal, U. Platzbecker, A.M. Zeidan
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-09-01
Online Access:	https://haematologica.org/article/view/12815